Search
for
Sort by
Research 361–390 of 766
- Cutaneous Manifestations of Eating Disorders
- Sexuality in premature ovarian insufficiency
- Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients
- Polycystic ovary syndrome is associated with anogenital distance, a marker of prenatal androgen exposure
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Contemporary medical therapy for polycystic ovary syndrome
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- Steroidogenic Isoenzymes in Human Hair and Their Potential Role in Androgenetic Alopecia
- Management of the Female With Non-classical Congenital Adrenal Hyperplasia (NCCAH): A Patient-Oriented Approach
- Acne in women
- Nonclassic congenital adrenal hyperplasia
- Diagnostic approach to low‐renin hypertension
- A Review of hormone-based therapies to treat adult acne vulgaris in women
- Endocrine evaluation of hirsutism
- 5α-Reductase inhibitors in androgenetic alopecia
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?
- Gender-Affirming Hormone Therapy for Transgender Men
- Does a male polycystic ovarian syndrome equivalent exist?
- Polycystic ovarian syndrome
- How to Diagnose Hair Loss
- Changes of androgens levels in menopausal women
- Towards a consensus on how to diagnose and quantify female pattern hair loss – The ‘Female Pattern Hair Loss Severity Index (FPHL-SI)’
- Hirsutism: diagnosis and treatment
- Congenital adrenal hyperplasia
- The diagnosis of nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, based on serum basal or post-ACTH stimulation 17-hydroxyprogesterone, can lead to false-positive diagnosis
- Hormone therapy in acne
- Female pattern hair loss
- Evaluation of androgen receptor gene as a candidate gene in female androgenetic alopecia
- Acne severity and the Global Acne Grading System in polycystic ovary syndrome